Agents of Behemoth
2.4K views | +0 today
Follow
Agents of Behemoth
Operation Deimos
Curated by Occupy Hades
Your new post is loading...
Scooped by Occupy Hades
Scoop.it!

Oklahoma City Home Health Company and Two Former Corporate Officers Agree to Pay $22.9 Million to Settle Federal False Claims Act and Kickback Allegations.... - Justice.gov

Oklahoma City Home Health Company and Two Former Corporate Officers Agree to Pay $22.9 Million to Settle Federal False Claims Act and Kickback Allegations.... - Justice.gov | Agents of Behemoth | Scoop.it

Department of Justice U.S. Attorney’s Office Western District of Oklahoma FOR IMMEDIATE RELEASE Tuesday, October 18, 2022 Oklahoma City Home Health Company and Two Former Corporate Officers Agree to Pay $22.9 Million to Settle Federal False Claims Act and Kickback Allegations...

No comment yet.
Scooped by Occupy Hades
Scoop.it!

First-ever False Claims Act settlement received from Paycheck Protection Program lender | USAO-SDTX | Department of Justice

First-ever False Claims Act settlement received from Paycheck Protection Program lender | USAO-SDTX | Department of Justice | Agents of Behemoth | Scoop.it

Prosperity Bank has agreed to pay $18,673.50 to resolve allegations it improperly processed a Paycheck Protection Program (PPP) loan on behalf of an ineligible customer

No comment yet.
Scooped by Occupy Hades
Scoop.it!

Biogen Inc. Agrees to Pay $900 Million to Settle False Claims Act Allegations Related to Improper Physician Payments | USAO-MA | Department of Justice

Biogen Inc. Agrees to Pay $900 Million to Settle False Claims Act Allegations Related to Improper Physician Payments | USAO-MA | Department of Justice | Agents of Behemoth | Scoop.it

BOSTON – Pharmaceutical company Biogen Inc. (Biogen), based in Cambridge, Massachusetts, has agreed to pay $900 million to resolve allegations that it violated the False Claims Act by causing the submission of false claims to Medicare and Medicaid by paying kickbacks to physicians to induce them to prescribe Biogen drugs.

No comment yet.